Robert A. Newman, Ph.D., Scientific Advisor.
Dr. Newman obtained his M.S. and Ph.D. degrees in Pharmacology and Toxicology from the University of Connecticut and then served in postdoctoral positions at the Medical School of the University of Georgia as well as the Department of Biochemistry at the University of Vermont. He served as a faculty member at the University of Vermont Medical School for seven years and then spent a sabbatical year at Stanford University performing research on immune targeted therapy. He has spent the last 24 years at the University of Texas M. D. Anderson Cancer Center in Houston, Texas where he served as the founder and Co-Director of the Pharmaceutical Development Center. He has published over 270 articles dealing with the pharmacology, toxicology and development of anticancer drugs. Dr. Newman remains actively involved in continuing research as Scientific Advisor to Nerium.
Richard A. Evans, M.D., Medical Advisor.
Dr. Evans currently is in General Practice, Cancer Consultation, and Medical Writing in Houston, Texas. He is a Diplomate of The American Board of Surgery. Dr. Evans worked with the late Dr. J. S. Stehlin, Jr., founder of the Stehlin Foundation, a world renowned cancer research facility located in Houston, Texas, and is co-author with Dr. Stehlin of several medical treatises dealing with cancer. Additionally, Dr. Evans is a prolific author in his own right publishing many articles on cancer and related immunology. Dr. Evans brings a comprehensive set of skills with him that Nerium believes will enable us to integrate, evaluate, and analyze the relationship between oncogenesis and immune response both in the treatment of a naïve patient and the patient receiving various therapeutic agents.
Keith I. Block, M.D., Medical Advisor.
Dr. Block is an internationally recognized integrative cancer-care specialist and visiting lecturer. As Medical Director of the Block Center for Integrative Cancer Care in Skokie, Illinois, the Block Center is committed to caring for people with cancer and improving total wellness through the integration of research-based complementary therapies with innovative approaches to conventional medicine. Dr. Block is the Director of Integrative Medical Education and the Clinical Assistant Professor, Department of Medical Education for the College of Medicine, University of Illinois at Chicago. While too numerous to list all governmental, teaching, and professional appointments here, Dr. Block is Editor-In-Chief of Integrated Cancer Therapies, Sage Science Press, a Member of The Editorial Board for Physician Data Query, CAM, National Cancer Institute, Bethesda, Maryland, and Scientific Director of the Institute for Integrative Cancer Research and Education. He brings first-hand clinical knowledge of Anvirzel™ and its effects through his observations of patients receiving Anvirzel™ therapy.
Donald E. Baxter, M.D., International Medical Advisor.
Dr. Baxter is an internationally renowned and board-certified orthopedic surgeon with a private practice in Houston, Texas. He has been a Clinical Professor of Orthopedic Surgery at both Baylor College of Medicine and the University of Texas Health Science Center. While too numerous to list here, Dr. Baxter is the author of many papers and books. He is also an international and visiting lecturer. Additionally, Dr. Baxter is a past president and director of the Texas Neurofibromatosis Foundation. He brings first hand knowledge of Anvirzel™ and its effects through his personal observations of family and friends receiving Anvirzel™ therapy.
Charles R. Hughes, Branding and Marketing Advisor.
Mr. Hughes is the founder and presently operates Brand Rules, LLC, located in Severna Park, MD. Brand Rules is a consulting consortium that applies decades of experience to create, shape, and sustain successful brands. It guides clients in developing a differentiating market strategy, an engaged culture, and effective execution of product, marketing, and retail. Clients include Hyundai, Kia, Ford, and Zodiac as well as start-ups, not-for-profits, and marketing companies. Mr. Hughes was the founder, President, and CEO of Land Rover North America, BMW Group located in Lanham, Maryland. As Chief Executive Officer, he presided over a $1 billion, 24,000-unit sales enterprise that successfully introduced the first Range Rover then Land Rover to the North American market. Nerium believes that Mr. Hughes’ experience with successfully building, branding, marketing, and expanding start-ups will be invaluable to Nerium.
Donald R. Gardner, Business Advisor.
Mr. Gardner graduated from the University of North Texas with a BBA in Business and Personnel Management. Mr. Gardner has spent the past 35 years as an entrepreneur in diverse areas of business both domestically in the US and internationally. During Mr. Gardner’s early career, he personally founded and operated multiple restaurants and night clubs. All were start-ups as opposed to acquisitions. He has served as consultant, investor, founder/owner, and operator with responsibility for development, design, and construction for various gaming interests and casinos both nationally and internationally. Mr. Garner was the founder of a software service company marketing code remediation and providing software services to Federal governments and large corporations, nationally and internationally. Mr. Gardner is currently involved in the construction business specializing in restaurant construction and along with his partner has built over 400 restaurants in the US. He remains active in software development and is involved in early stage development of trading software with Trade Point Technologies. He has served on numerous boards and committees of various corporations. Mr. Gardner’s entrepreneurial success and diverse business/start-up experience provides valuable insight and direction to Nerium Biotechnology for its future growth and foundational development.Top